A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A von Peyvandi, Flora, Mannucci, Pier M, Garagiola, Isabella, El-Beshlawy, Amal, Elalfy, Mohsen, Ramanan, Vijay, Eshghi, Peyman, Hanagavadi, Suresh, Varadarajan, Ramabadran, Karimi, Mehran, Manglani, Mamta V, Ross, Cecil, Young, Guy, Seth, Tulika, Apte, Shashikant, Nayak, Dinesh M, Santagostino, Elena, Mancuso, Maria Elisa, Sandoval Gonzalez, Adriana C, Mahlangu, Johnny N, Bonanad Boix, Santiago, Cerqueira, Monica, Ewing, Nadia P, Male, Christoph, Owaidah, Tarek, Soto Arellano, Veronica, Kobrinsky, Nathan L, Majumdar, Suvankar, Perez Garrido, Rosario, Sachdeva, Anupam, Simpson, Mindy, Thomas, Mathew, Zanon, Ezio, Antmen, Bulent, Kavakli, Kaan, Manco-Johnson, Marilyn J, Martinez, Monica, Marzouka, Esperanza, Mazzucconi, Maria G, Neme, Daniela, Palomo Bravo, Angeles, Paredes Aguilera, Rogelio, Prezotti, Alessandra, Schmitt, Klaus, Wicklund, Brian M, Zulfikar, Bulent, Rosendaal, Frits R

Volltext

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include Up-Regulated Innate Immune Modulators von Karim, Ahmad Faisal, Soltis, Anthony R, Sukumar, Gauthaman, Königs, Christoph, Ewing, Nadia P, Dalgard, Clifton L, Wilkerson, Matthew D, Pratt, Kathleen P

Volltext

The principal results of the International Immune Tolerance Study: a randomized dose comparison von Hay, Charles R.M., DiMichele, Donna M.

Volltext

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators von Karim, Ahmad Faisal, Soltis, Anthony R., Ewing, Nadia P, Dalgard, Clifton L., Wilkerson, Matthew D., Pratt, Kathleen P.

Volltext

Correlations of Plasma Cytokine Levels and Anti-FVIII Antibodies during Immune Tolerance Induction von Hartmann, Johannes, Schmidt, Anja, Beilfuss, Marko, Stichel, Diana, Heller, Christine, Schwabe, Dirk, Klingebiel, Thomas, Ewing, Nadia P, Koenigs, Christoph

Volltext

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis von Rosendaal, Frits R., Palla, Roberta, Garagiola, Isabella, Mannucci, Pier M., Peyvandi, Flora, for the SIPPET Study Group

Volltext

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A von Cannavò, Antonino, Valsecchi, Carla, Garagiola, Isabella, Palla, Roberta, Mannucci, Pier Mannuccio, Rosendaal, Frits R., Peyvandi, Flora

Volltext

Therapeutic choices for patients with hemophilia and high‐titer inhibitors von Kulkarni, Roshni, Aledort, Louis M., Berntorp, Erik, Brackman, Hans H., Brown, Deborah, Cohen, Alan R., Ewing, Nadia P., Gringeri, Alessandro, Gruppo, Ralph, Hoots, Keith, Leissenger, Cindy, Peerlinck, Katheliijne, Poon, Man‐Chiu, Wong, Wing‐Yen

Volltext

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort von Astermark, Jan, Donfield, Sharyne M., Gomperts, Edward D., Schwarz, John, Menius, Erika D., Pavlova, Anna, Oldenburg, Johannes, Kessing, Bailey, DiMichele, Donna M., Shapiro, Amy D., Winkler, Cheryl A., Berntorp, Erik

Volltext

Venous Thromboembolism Risk Assessment and Prophylaxis Use in Pediatric, Adolescent, and Young Adult Hematology Oncology Patients von Bell, Alison D, Hockenberry, Marilyn, Landier, Wendy, Ewing, Nadia

Volltext

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study von Peyvandi, Flora, Bucciarelli, Paolo, Valsecchi, Carla, Boscarino, Marco, Palla, Roberta, Santagostino, Elena, El-Beshlawy, Amal, Elalfy, Mohsen Saleh, Ramanan, Vijay M., Eshghi, Peyman, Hanagavadi, Suresh, Karimi, Mehran, Ross, Cecil, Manglani, Mamta V, Young, Guy, Seth, Tulika, Apte, Shashikant, Nayak, Dinesh M, Mancuso, Maria Elisa, Mahlangu, Johnny, Santiago, Bonanad, Cerqueira, Monica H, Ewing, Nadia P, Male, Christoph, Owaidah, Tarek, Soto Arellano, Veronica, Majumdar, Suvankar, Simpson, Mindy, Thomas, Mathew, Zanon, Ezio, Manco-Johnson, Marilyn J, Martinez, Monica, Mazzucconi, Maria Gabriella, Neme, Daniela, Paredes-Aguilera, Rogelio Alejandro, Prezotti, Alessandra N L, Schmitt, Klaus, Zulfikar, Bulent, Mannucci, Pier Mannuccio, Rosendaal, Frits Richard

Volltext

Consequences of Switching From Prophylactic Treatment to On-Demand Treatment in Late Teens and Early Adults with Severe Hemophilia A. the TEEN/TWEN Study von Manco-Johnson, Marilyn J., Sanders, Joann, Ewing, Nadia, Humphries, Thomas J.

Volltext

F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort von Schwarz, J., Astermark, J., Menius, E. D., Carrington, M., Donfield, S. M., Gomperts, E. D., Nelson, G. W., Oldenburg, J., Pavlova, A., Shapiro, A. D., Winkler, C. A., Berntorp, E.

Volltext

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter R... von Peyvandi, Flora, Mannucci, Pier Mannuccio, Garagiola, Isabella, Elalfy, Mohsen, El-Beshlawy, Amal, Ramanan, Madatha V., Eshghi, Peyman, Hanagavadi, Suresh, Varadarajan, Ramabadran, Karimi, Mehran, Manglani, Mamta V., Ross, Cecil, Young, Guy, Seth, Tulika, Apte, Shashikant, Nayak, Dinesh M., Sandoval Gonzales, Adriana C., Santagostino, Elena, Mancuso, Maria Elisa, Mahlangu, Johnny N., Bonanad, Santiago, Cerqueira, Monica, Ewing, Nadia P., Male, Christoph, Owaidah, Tarek, Soto Arellano, Veronica, Kobrinsky, Nathan L., Majumdar, Suvankar, Perez Garrido, Rosario, Sachdeva, Anupam, Simpson, Mindy, Thomas, Mathew, Zanon, Ezio, Antmen, ALI Bulent, Kavakli, Kaan, Manco-Johnson, Marilyn, Martinez, Monica, Marzouka, Esperanza, Mazzucconi, Maria Gabriella, Neme, Daniela, Palomo Bravo, Angeles, Paredes Aguilera, Rogelio, Prezotti, Alessandra Nunes Loureiro, Klaus, Schmitt, Wicklund, Brian M., Zulfikar, Bulent, Frits, Rosendaal R.

Volltext

Identifying Nonresponsive Bleeding Episodes in Patients With Haemophilia and Inhibitors: A Consensus Definition von Berntorp, Erik, Collins, Peter, d'Oiron, Roseline, Ewing, Nadia, Gringeri, Alessandro, Negrier, Claude

Volltext

International Consortium for the Study of Clinical and Molecular Aspects of Bernard-Soulier Syndrome von Savoia, Anna, Kunishima, Shinji, Noris, Patrizia, Pujol-Moix, Nuria, Kenny, Dermot, Rosenberg, Nurit, Rand, Margaret L., Zieger, Barbara, Gargouri, Ali F., Beltrame, Miriam P, Molinas, Felisa C., Karimi, Mehran, Ward, Christopher, Kuriakose, Philip, Ewing, Nadia, Diamond, Carol, Srivastava, Alok, Balduini, Carlo Luigi, Lanza, Francois

Volltext

A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibi... von Mahlangu, Johnny, Andreeva, Tatiana A., Macfarlane, Donald, Reding, Mark T., Walsh, Christopher, Ritchie, Bruce, Ewing, Nadia, Kessler, Craig M., Kempton, Christine, Libby, Edward, Zozulya, Nadezda, Shapiro, Amy D., St-Louis, Jean, Warrier, Indira, Hoots, W. Keith, Gruppo, Ralph A., Mueksch, Josef N.

Volltext

Cerebral vasculopathy in sickle cell anemia : Diagnostic contribution of positron emission tomography von POWARS, D. R, CONTI, P. S, HITI, A. L, TENG, E. L, CHAN, L. S, WONG, W.-Y, GRONCY, P, HYMAN, C, SMITH, E, EWING, N, KEENAN, R. N, ZEE, C.-S, HAROLD, Y

Volltext

KarimAF et al. RNA seq normalized counts.xlsx von Karim, Ahmad, Soltis, Anthony, Sukumar, Gauthaman, Königs, Christoph, Ewing, Nadia, Dalgard, Clifton, Wilkerson, Mathew, Pratt, Kathleen

Volltext bestellen

Therapeutic choices for patients with hemophilia and high‐titer inhibitors von Kulkarni, Roshni, Aledort, Louis M., Berntorp, Erik, Brackman, Hans H., Brown, Deborah, Cohen, Alan R., Ewing, Nadia P., Gringeri, Alessandro, Gruppo, Ralph, Hoots, Keith, Leissenger, Cindy, Peerlinck, Katheliijne, Poon, Man‐Chiu, Wong, Wing‐Yen

Volltext